Scrotal cancer: Incidence, survival and second primary tumours in the Netherlands since 1989
2010-10-28
Article
| Related Files |
|---|
|
Redirect to Publisher's version
(Publisher's version.url.txt, 40 bytes) |
Background: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. Methods: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. Results: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour. Conclusion: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers.
- adult
- article
- human
- male
- aged
- major clinical study
- priority journal
- Netherlands
- neoplasms
- cancer incidence
- cancer survival
- incidence
- cancer staging
- squamous cell carcinoma
- primary tumor
- basal cell carcinoma
- survival rate
- carcinoma
- Bowen disease
- scrotum cancer
- second primary
- scrotum
- testis cancer
- squamous cell